Standards of diagnostic assessment for autism spectrum disorder.

Autism spectrum disorder Diagnostic evaluation Intervention planning

Journal

Paediatrics & child health
ISSN: 1205-7088
Titre abrégé: Paediatr Child Health
Pays: England
ID NLM: 9815960

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 08 01 2019
accepted: 27 03 2019
entrez: 30 10 2019
pubmed: 30 10 2019
medline: 30 10 2019
Statut: ppublish

Résumé

The rising prevalence of autism spectrum disorder (ASD) has created a need to expand ASD diagnostic capacity by community-based paediatricians and other primary care providers. Although evidence suggests that some children can be definitively diagnosed by 2 years of age, many are not diagnosed until 4 to 5 years of age. Most clinical guidelines recommend multidisciplinary team involvement in the ASD diagnostic process. Although a maximal wait time of 3 to 6 months has been recommended by three recent ASD guidelines, the time from referral to a team-based ASD diagnostic evaluation commonly takes more than a year in many Canadian communities. More paediatric health care providers should be trained to diagnose less complex cases of ASD. This statement provides community-based paediatric clinicians with recommendations, tools, and resources to perform or assist in the diagnostic evaluation of ASD. It also offers guidance on referral for a comprehensive needs assessment both for treatment and intervention planning, using a flexible, multilevel approach.

Identifiants

pubmed: 31660042
doi: 10.1093/pch/pxz117
pii: pxz117
pmc: PMC6812299
doi:

Types de publication

Journal Article Review

Langues

eng fre

Pagination

444-460

Informations de copyright

© Canadian Paediatric Society 2019. Published by Oxford University Press on behalf of the Canadian Paediatric Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Pediatrics. 2011 Sep;128(3):e488-95
pubmed: 21844053
J Am Acad Child Adolesc Psychiatry. 2014 Feb;53(2):237-57
pubmed: 24472258
BMJ. 2018 May 21;361:k1674
pubmed: 29784657
Cochrane Database Syst Rev. 2018 Jul 24;7:CD009044
pubmed: 30075057
Paediatr Child Health. 2018 Sep;23(6):403-419
pubmed: 30919832
J Am Acad Child Adolesc Psychiatry. 2004 May;43(5):548-58
pubmed: 15100561
Am J Hum Genet. 2010 May 14;86(5):749-64
pubmed: 20466091
J Autism Dev Disord. 2018 Sep;48(9):2968-2979
pubmed: 29644584
Autism. 2012 Sep;16(5):487-97
pubmed: 21690082
Front Psychol. 2017 Apr 20;8:590
pubmed: 28473784
J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):11-24
pubmed: 25524786
Nat Rev Genet. 2017 Jun;18(6):362-376
pubmed: 28260791
Pediatrics. 2007 Nov;120(5):1183-215
pubmed: 17967920
Eur Child Adolesc Psychiatry. 2013 Jun;22(6):329-40
pubmed: 23322184
MMWR Surveill Summ. 2018 Apr 27;67(6):1-23
pubmed: 29701730
Pediatrics. 2009 May;123(5):1383-91
pubmed: 19403506
Mol Autism. 2018 Mar 6;9:16
pubmed: 29541438
Autism. 2018 Jul;22(5):517-527
pubmed: 28548543
CMAJ. 2014 Apr 15;186(7):509-19
pubmed: 24418986
Int J Ment Health Addict. 2017;15(2):239-259
pubmed: 28424567

Auteurs

Jessica A Brian (JA)

Canadian Paediatric Society, Autism Spectrum Disorder Guidelines Task Force, Ottawa, Ontario.

Lonnie Zwaigenbaum (L)

Canadian Paediatric Society, Autism Spectrum Disorder Guidelines Task Force, Ottawa, Ontario.

Angie Ip (A)

Canadian Paediatric Society, Autism Spectrum Disorder Guidelines Task Force, Ottawa, Ontario.

Classifications MeSH